Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00094094 · COMPLETED

Trial details

NCT number: NCT00094094
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Neoplasms Carcinoma, Non-small Cell Lung

Start date: 2005-02-01
Primary completion: 2007-07-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.